{"hands_on_practices": [{"introduction": "A single serological test result is rarely interpreted in isolation. This exercise challenges you to apply Bayes' theorem, the cornerstone of diagnostic reasoning, to calculate the post-test probability of a disease. By working from first principles, you will solidify your understanding of how a test's performance characteristics (sensitivity and specificity) interact with the pre-test probability (prevalence) to determine the true meaning of a positive result [@problem_id:5160997].", "problem": "A public health laboratory validates a serological Enzyme-Linked Immunosorbent Assay (ELISA) for Immunoglobulin M (IgM) against an emerging arbovirus. In the intended testing population, prior clinical and epidemiological assessment yields a pre-test probability of disease $\\Pr(D) = 0.08$. Independent validation against a reference standard in the same population finds the probability of a positive test among truly diseased individuals (clinical sensitivity) $\\Pr(T^{+} \\mid D) = 0.92$ and the probability of a positive test among truly non-diseased individuals (false-positive rate) $\\Pr(T^{+} \\mid \\neg D) = 0.03$.\n\nUsing only fundamental probabilistic principles applicable to serological testing for infectious diseases—specifically Bayes' theorem and the definitions of sensitivity, specificity, and the positive likelihood ratio—derive the post-test probability of disease given a positive test $\\Pr(D \\mid T^{+})$ from first principles. Express your final answer as a simplified fraction. Do not use a percentage sign.", "solution": "The objective is to find the post-test probability of disease given a positive test result, denoted as $\\Pr(D \\mid T^{+})$. This quantity is also known as the positive predictive value (PPV). The derivation will proceed from Bayes' theorem.\n\nThe given values are:\n- Pre-test probability of disease: $\\Pr(D) = 0.08$\n- Clinical sensitivity: $\\Pr(T^{+} \\mid D) = 0.92$\n- False-positive rate: $\\Pr(T^{+} \\mid \\neg D) = 0.03$\n\nAccording to the definition of conditional probability, Bayes' theorem can be stated as:\n$$ \\Pr(D \\mid T^{+}) = \\frac{\\Pr(D \\cap T^{+})}{\\Pr(T^{+})} = \\frac{\\Pr(T^{+} \\mid D) \\Pr(D)}{\\Pr(T^{+})} $$\nThe denominator, $\\Pr(T^{+})$, is the total probability of obtaining a positive test result, calculated using the law of total probability:\n$$ \\Pr(T^{+}) = \\Pr(T^{+} \\mid D)\\Pr(D) + \\Pr(T^{+} \\mid \\neg D)\\Pr(\\neg D) $$\nCombining these gives the full form of Bayes' theorem for this problem:\n$$ \\Pr(D \\mid T^{+}) = \\frac{\\Pr(T^{+} \\mid D) \\Pr(D)}{\\Pr(T^{+} \\mid D)\\Pr(D) + \\Pr(T^{+} \\mid \\neg D)\\Pr(\\neg D)} $$\nFirst, we calculate the probability of a subject not having the disease: $\\Pr(\\neg D) = 1 - \\Pr(D)$.\n$$ \\Pr(\\neg D) = 1 - 0.08 = 0.92 $$\nNow, we substitute the given values into the formula:\n$$ \\Pr(D \\mid T^{+}) = \\frac{(0.92)(0.08)}{(0.92)(0.08) + (0.03)(0.92)} $$\nWe can simplify by factoring out the common term $0.92$ from the denominator:\n$$ \\Pr(D \\mid T^{+}) = \\frac{(0.92)(0.08)}{0.92 \\times (0.08 + 0.03)} $$\nCanceling the common factor of $0.92$ yields:\n$$ \\Pr(D \\mid T^{+}) = \\frac{0.08}{0.08 + 0.03} = \\frac{0.08}{0.11} $$\nTo express this as a simplified fraction:\n$$ \\frac{0.08}{0.11} = \\frac{8/100}{11/100} = \\frac{8}{11} $$\nThe integers $8$ and $11$ are coprime, so the fraction is in its simplest form.\n\nAlternatively, using the odds-likelihood ratio method:\nThe pre-test odds of disease are:\n$$ \\text{Odds}(D) = \\frac{\\Pr(D)}{1 - \\Pr(D)} = \\frac{0.08}{0.92} = \\frac{8}{92} = \\frac{2}{23} $$\nThe positive likelihood ratio ($LR^{+}$) is:\n$$ LR^{+} = \\frac{\\Pr(T^{+} \\mid D)}{\\Pr(T^{+} \\mid \\neg D)} = \\frac{0.92}{0.03} = \\frac{92}{3} $$\nThe post-test odds are the product of the pre-test odds and the likelihood ratio:\n$$ \\text{Odds}(D \\mid T^{+}) = \\text{Odds}(D) \\times LR^{+} = \\left(\\frac{2}{23}\\right) \\times \\left(\\frac{92}{3}\\right) = \\frac{2 \\times (4 \\times 23)}{23 \\times 3} = \\frac{8}{3} $$\nFinally, we convert the post-test odds back to a probability:\n$$ \\Pr(D \\mid T^{+}) = \\frac{\\text{Odds}(D \\mid T^{+})}{1 + \\text{Odds}(D \\mid T^{+})} = \\frac{8/3}{1 + 8/3} = \\frac{8/3}{11/3} = \\frac{8}{11} $$\nBoth methods yield the same result. The post-test probability of disease, given a positive test, is $\\frac{8}{11}$.", "answer": "$$\\boxed{\\frac{8}{11}}$$", "id": "5160997"}, {"introduction": "For low-prevalence diseases, a single screening test often produces an unacceptably high number of false positives. This practice simulates a common real-world solution: the sequential confirmatory algorithm, where a sensitive screen is followed by a highly specific confirmatory test. You will calculate the overall Positive Predictive Value ($PPV$) for two such algorithms, directly comparing how different confirmatory tests impact diagnostic confidence and highlighting the trade-offs between sensitivity and specificity in a multi-step strategy [@problem_id:5161003].", "problem": "A clinical laboratory deploys two sequential confirmatory algorithms for a low-prevalence infectious disease serology program. Both algorithms begin with an Enzyme-Linked Immunosorbent Assay (ELISA) screen and proceed to an immunoblot (IB) only if the ELISA is reactive. The final reportable positive requires a reactive ELISA followed by a positive IB. Assume conditional independence of test outcomes given true infection status, and that non-reactive or indeterminate IB results are treated as negative for the purpose of final reporting.\n\nLet the population infection prevalence be $p = 0.005$. The ELISA has sensitivity $\\mathrm{Se}_{E} = 0.997$ and specificity $\\mathrm{Sp}_{E} = 0.985$.\n\nTwo confirmatory IBs are considered:\n- Algorithm A uses IB-A with sensitivity $\\mathrm{Se}_{A} = 0.980$ and specificity $\\mathrm{Sp}_{A} = 0.999$.\n- Algorithm B uses IB-B with sensitivity $\\mathrm{Se}_{B} = 0.960$ and specificity $\\mathrm{Sp}_{B} = 0.9997$.\n\nUsing only first principles (the definitions of sensitivity, specificity, and Bayes’ theorem), derive the overall Positive Predictive Value (PPV) under each sequential algorithm, defined as $PPV = P(\\text{Disease} \\mid \\text{Final Positive})$, where “Final Positive” means ELISA reactive and IB positive. Then compute the difference $PPV_{B} - PPV_{A}$.\n\nExpress the final answer as a decimal fraction and round your answer to four significant figures.", "solution": "Let $D$ denote the event that an individual has the disease, and $D^c$ denote the event that the individual does not have the disease. The prevalence is given as $P(D) = p = 0.005$, so $P(D^c) = 1 - p = 1 - 0.005 = 0.995$.\n\nLet $E^+$ be the event of a reactive (positive) ELISA test and $I^+$ be the event of a positive immunoblot (IB) test. The final reportable positive result for an algorithm, which we denote as $F^+$, occurs when both the ELISA is reactive and the subsequent IB is positive. Thus, $F^+ = E^+ \\cap I^+$.\n\nThe Positive Predictive Value (PPV) is the probability that a person with a positive test result is truly diseased. For the sequential algorithm, this is $PPV = P(D \\mid F^+) = P(D \\mid E^+ \\cap I^+)$.\n\nAccording to Bayes' theorem, the PPV can be expressed as:\n$$PPV = \\frac{P(E^+ \\cap I^+ \\mid D) P(D)}{P(E^+ \\cap I^+)}$$\nThe denominator, $P(E^+ \\cap I^+)$, can be expanded using the law of total probability:\n$$P(E^+ \\cap I^+) = P(E^+ \\cap I^+ \\mid D) P(D) + P(E^+ \\cap I^+ \\mid D^c) P(D^c)$$\nThe problem states that the outcomes of the ELISA and IB tests are conditionally independent given the true infection status. This allows us to write:\n- For truly diseased individuals: $P(E^+ \\cap I^+ \\mid D) = P(E^+ \\mid D) \\times P(I^+ \\mid D)$. This is the product of the sensitivities of the two tests. Let's call this the serial sensitivity, $\\mathrm{Se}_{\\text{series}}$.\n- For non-diseased individuals: $P(E^+ \\cap I^+ \\mid D^c) = P(E^+ \\mid D^c) \\times P(I^+ \\mid D^c)$. This is the product of the false positive rates of the two tests. The false positive rate of a test is $1 - \\text{specificity}$.\n\nThe given parameters are:\n- ELISA sensitivity: $\\mathrm{Se}_{E} = P(E^+ \\mid D) = 0.997$\n- ELISA specificity: $\\mathrm{Sp}_{E} = P(E^- \\mid D^c) = 0.985$, so $P(E^+ \\mid D^c) = 1 - \\mathrm{Sp}_{E} = 1 - 0.985 = 0.015$.\n\nFor Algorithm A, using IB-A:\n- IB-A sensitivity: $\\mathrm{Se}_{A} = P(I_A^+ \\mid D) = 0.980$\n- IB-A specificity: $\\mathrm{Sp}_{A} = P(I_A^- \\mid D^c) = 0.999$, so $P(I_A^+ \\mid D^c) = 1 - \\mathrm{Sp}_{A} = 1 - 0.999 = 0.001$.\n\nFor Algorithm B, using IB-B:\n- IB-B sensitivity: $\\mathrm{Se}_{B} = P(I_B^+ \\mid D) = 0.960$\n- IB-B specificity: $\\mathrm{Sp}_{B} = P(I_B^- \\mid D^c) = 0.9997$, so $P(I_B^+ \\mid D^c) = 1 - \\mathrm{Sp}_{B} = 1 - 0.9997 = 0.0003$.\n\nThe general formula for the PPV of the sequential algorithm is:\n$$PPV = \\frac{\\left( \\mathrm{Se}_{E} \\times \\mathrm{Se}_{I} \\right) \\times p}{\\left( \\mathrm{Se}_{E} \\times \\mathrm{Se}_{I} \\right) \\times p + \\left( (1 - \\mathrm{Sp}_{E}) \\times (1 - \\mathrm{Sp}_{I}) \\right) \\times (1 - p)}$$\nwhere $\\mathrm{Se}_{I}$ and $\\mathrm{Sp}_{I}$ are the sensitivity and specificity of the specific immunoblot used.\n\nNow, we calculate the PPV for each algorithm.\n\n**Algorithm A (using IB-A):**\n- Serial sensitivity: $\\mathrm{Se}_{\\text{series, A}} = \\mathrm{Se}_{E} \\times \\mathrm{Se}_{A} = 0.997 \\times 0.980 = 0.97706$.\n- Serial false positive probability for non-diseased individuals: $P(F_A^+ \\mid D^c) = (1 - \\mathrm{Sp}_{E}) \\times (1 - \\mathrm{Sp}_{A}) = 0.015 \\times 0.001 = 0.000015$.\nThe numerator of the PPV formula is the probability of a true positive result:\n$$P(F_A^+ \\cap D) = \\mathrm{Se}_{\\text{series, A}} \\times p = 0.97706 \\times 0.005 = 0.0048853$$\nThe probability of a false positive result is:\n$$P(F_A^+ \\cap D^c) = P(F_A^+ \\mid D^c) \\times P(D^c) = 0.000015 \\times 0.995 = 0.000014925$$\nSo, the PPV for Algorithm A is:\n$$PPV_{A} = \\frac{P(F_A^+ \\cap D)}{P(F_A^+ \\cap D) + P(F_A^+ \\cap D^c)} = \\frac{0.0048853}{0.0048853 + 0.000014925} = \\frac{0.0048853}{0.004900225} \\approx 0.996954316$$\n\n**Algorithm B (using IB-B):**\n- Serial sensitivity: $\\mathrm{Se}_{\\text{series, B}} = \\mathrm{Se}_{E} \\times \\mathrm{Se}_{B} = 0.997 \\times 0.960 = 0.95712$.\n- Serial false positive probability for non-diseased individuals: $P(F_B^+ \\mid D^c) = (1 - \\mathrm{Sp}_{E}) \\times (1 - \\mathrm{Sp}_{B}) = 0.015 \\times 0.0003 = 0.0000045$.\nThe numerator of the PPV formula is the probability of a true positive result:\n$$P(F_B^+ \\cap D) = \\mathrm{Se}_{\\text{series, B}} \\times p = 0.95712 \\times 0.005 = 0.0047856$$\nThe probability of a false positive result is:\n$$P(F_B^+ \\cap D^c) = P(F_B^+ \\mid D^c) \\times P(D^c) = 0.0000045 \\times 0.995 = 0.0000044775$$\nSo, the PPV for Algorithm B is:\n$$PPV_{B} = \\frac{P(F_B^+ \\cap D)}{P(F_B^+ \\cap D) + P(F_B^+ \\cap D^c)} = \\frac{0.0047856}{0.0047856 + 0.0000044775} = \\frac{0.0047856}{0.0047900775} \\approx 0.999065250$$\n\n**Difference in PPV:**\nFinally, we compute the difference $PPV_{B} - PPV_{A}$:\n$$PPV_{B} - PPV_{A} \\approx 0.999065250 - 0.996954316 = 0.002110934$$\nThe problem requires the answer to be rounded to four significant figures.\nThe first non-zero digit is in the thousandths place. The four significant figures are $2, 1, 1, 0$. The next digit is $9$, so we round up the last significant digit.\n$$PPV_{B} - PPV_{A} \\approx 0.002111$$\nThis result indicates that Algorithm B, despite having a lower sensitivity in its confirmatory step, achieves a higher overall Positive Predictive Value due to its significantly higher specificity, which substantially reduces the number of false positives in this low-prevalence setting.", "answer": "$$\\boxed{0.002111}$$", "id": "5161003"}, {"introduction": "Moving beyond simple positive or negative results, functional assays like the Plaque Reduction Neutralization Test (PRNT) quantify the biological activity of antibodies. This problem puts you in the role of a laboratory scientist, tasking you with processing raw assay data to determine the $PRNT_{50}$ titer. You will use the standard method of log-transformation and linear interpolation, a critical skill for translating a dose-response curve into a single, clinically meaningful value representing the potency of neutralizing antibodies [@problem_id:5161041].", "problem": "A Plaque Reduction Neutralization Test (PRNT) is performed to quantify neutralizing antibodies against an emerging arbovirus. The assay uses a constant virus inoculum and serial two-fold dilutions of a patient serum. For each serum dilution, the infection fraction is defined as the ratio of the plaque count in the presence of serum to the plaque count in the virus-only control, so that an infection fraction of $0$ corresponds to complete neutralization and an infection fraction of $1$ corresponds to no neutralization. The PRNT at $50\\%$ endpoint (PRNT$_{50}$) is defined as the reciprocal serum dilution at which the infection fraction equals $0.5$, corresponding to a $50\\%$ reduction in plaques relative to control.\n\nAssume the following scientifically consistent conditions:\n- The relationship between infection fraction and the base-$10$ logarithm of the reciprocal dilution is monotonic and locally well-approximated by a linear function between adjacent two-fold dilutions.\n- The dilution series is strictly two-fold, and the reciprocal dilutions are $20$, $40$, $80$, $160$, $320$, and $640$.\n\nThe measured infection fractions $p(D)$ at each reciprocal dilution $D$ are:\n- $D = 20$: $p(20) = 0.04$\n- $D = 40$: $p(40) = 0.12$\n- $D = 80$: $p(80) = 0.31$\n- $D = 160$: $p(160) = 0.47$\n- $D = 320$: $p(320) = 0.69$\n- $D = 640$: $p(640) = 0.86$\n\nStarting from the core definition of PRNT$_{50}$ and the assumption of local linearity in $\\log_{10}$-reciprocal-dilution space, determine the PRNT$_{50}$ titer (the reciprocal dilution at which $p(D) = 0.5$) by linear interpolation on the infection-fraction curve as a function of $\\log_{10}(D)$. Treat the curve between adjacent data points as piecewise linear. Express your final answer as a single number equal to the reciprocal dilution and round your answer to three significant figures. No units are required.", "solution": "The objective is to find the reciprocal dilution $D_{50}$ at which the infection fraction $p(D_{50})$ is equal to $0.5$. The problem mandates linear interpolation on a plot of infection fraction $p(D)$ versus the base-10 logarithm of the reciprocal dilution, $\\log_{10}(D)$.\n\nFirst, we identify the two consecutive data points that bracket the target infection fraction of $0.5$:\n- At reciprocal dilution $D_1 = 160$, the infection fraction is $p_1 = 0.47$.\n- At reciprocal dilution $D_2 = 320$, the infection fraction is $p_2 = 0.69$.\nSince $0.47 < 0.5 < 0.69$, the PRNT$_{50}$ titer lies between the reciprocal dilutions of $160$ and $320$.\n\nWe perform linear interpolation in the coordinate system $(x, y)$, where $x = \\log_{10}(D)$ and $y = p(D)$. Our two known points are $(x_1, y_1) = (\\log_{10}(160), 0.47)$ and $(x_2, y_2) = (\\log_{10}(320), 0.69)$. We want to find the value $x_{50} = \\log_{10}(D_{50})$ that corresponds to the target value $y_{50} = 0.5$.\n\nThe formula for linear interpolation is:\n$$ \\frac{y_{50} - y_1}{x_{50} - x_1} = \\frac{y_2 - y_1}{x_2 - x_1} $$\nRearranging to solve for $x_{50}$:\n$$ x_{50} = x_1 + (y_{50} - y_1) \\frac{x_2 - x_1}{y_2 - y_1} $$\nSubstituting the variable definitions:\n$$ \\log_{10}(D_{50}) = \\log_{10}(D_1) + (p_{50} - p_1) \\frac{\\log_{10}(D_2) - \\log_{10}(D_1)}{p_2 - p_1} $$\nNow, we substitute the numerical values:\n$$ \\log_{10}(D_{50}) = \\log_{10}(160) + (0.5 - 0.47) \\frac{\\log_{10}(320) - \\log_{10}(160)}{0.69 - 0.47} $$\n$$ \\log_{10}(D_{50}) = \\log_{10}(160) + \\frac{0.03}{0.22} (\\log_{10}(320) - \\log_{10}(160)) $$\nUsing the logarithm property $\\log(b) - \\log(a) = \\log(b/a)$:\n$$ \\log_{10}(D_{50}) = \\log_{10}(160) + \\frac{3}{22} \\left(\\log_{10}\\left(\\frac{320}{160}\\right)\\right) = \\log_{10}(160) + \\frac{3}{22} \\log_{10}(2) $$\nTo find $D_{50}$, we exponentiate both sides with base $10$:\n$$ D_{50} = 10^{\\left( \\log_{10}(160) + \\frac{3}{22} \\log_{10}(2) \\right)} = 10^{\\log_{10}(160)} \\times 10^{\\frac{3}{22} \\log_{10}(2)} $$\nUsing the property $10^{c \\log_{10}(x)} = x^c$:\n$$ D_{50} = 160 \\times 2^{3/22} $$\nCalculating the numerical value:\n$$ D_{50} \\approx 160 \\times 1.099115 \\approx 175.8584 $$\nRounding to three significant figures, we get:\n$$ D_{50} \\approx 176 $$", "answer": "$$\\boxed{176}$$", "id": "5161041"}]}